EMILY QUICK: Open Payments
NPI 1457034704 · HIGHLANDS RANCH, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,175 in 43 payments from 17 companies in 2025. Trend: 2023 $47 · 2024 $0 · 2025 $1,175
Food & beverage: $1,175
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $232 |
| Calliditas Therapeutics US Inc. | 6 | $167 |
| Mallinckrodt Hospital Products Inc. | 3 | $94 |
| AstraZeneca Pharmaceuticals LP | 4 | $90 |
| Otsuka America Pharmaceutical, Inc. | 3 | $88 |
| Travere Therapeutics, Inc. | 3 | $81 |
| Amgen Inc. | 2 | $63 |
| Ardelyx, Inc. | 2 | $56 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
Products named: TARPEYO, Fabhalta, ACTHAR, LOKELMA, Vanrafia, IBSRELA, JYNARQUE, JARDIANCE.
Industry payments across CO — which companies pay providers there.
